Related references
Note: Only part of the references are listed.When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists
Maris Vilums et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Gold-Catalyzed Carboalkoxylations of 2-Ethynylbenzyl Ethers to form 1-and 2-Indanones Chemoselectively: Effects of Ligands and Solvents
Chiou-Dong Wang et al.
ADVANCED SYNTHESIS & CATALYSIS (2014)
Enantio- and Regioselective Intermolecular Benzylic and Allylic C-H Bond Amination
Yota Nishioka et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Potent MCH-1 receptor antagonists from cis-1,4-diaminocyclohexane-derived indane analogs
Yimin Qian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Antidiabetic Effects of Pterosin A, a Small-Molecular-Weight Natural Product, on Diabetic Mouse Models
Feng-Lin Hsu et al.
DIABETES (2013)
Fasiglifam as a new potential treatment option for patients with type 2 diabetes
Kohei Kaku
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Structure-Kinetic Relationships-An Overlooked Parameter in Hit-to-Lead Optimization: A Case of Cyclopentylamines as Chemokine Receptor 2 Antagonists
Maris Vilums et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Tripartin, a Histone Demethylase Inhibitor from a Bacterium Associated with a Dung Beetle Larva
Seong-Hwan Kim et al.
ORGANIC LETTERS (2013)
Are GPCRs Still a Source of New Targets?
Stephen L. Garland
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Synthesis and SAR studies of bicyclic amine series GPR119 agonists
Masao Sakairi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
An investigation into the structure-activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol
David Beattie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)
Peter A. LeWitt et al.
NEUROLOGY (2012)
Enantioselective water-soluble iron-porphyrin-catalyzed epoxidation with aqueous hydrogen peroxide and hydroxylation with iodobenzene diacetate
Paul Le Maux et al.
TETRAHEDRON (2012)
Copy Number Variants in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for 3q29 Microdeletions and VIPR2 Duplications
Douglas F. Levinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia
Vladimir Vacic et al.
NATURE (2011)
Novel Agonists and Antagonists for Human Protease Activated Receptor 2
Grant D. Barry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist
Francois Baur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification and Characterization of a Small Molecule Antagonist of Human VPAC(2) Receptor
Alan Chu et al.
MOLECULAR PHARMACOLOGY (2010)
Analysis of the Indanomycin Biosynthetic Gene Cluster from Streptomyces antibioticus NRRL 8167
Chaoxuan Li et al.
CHEMBIOCHEM (2009)
Identification of Novel Indanylsulfonamide Guanylhydrazones as Potent 5-HT6 Serotonin Receptor Antagonists
Neus Mesquida et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Pharmacological Properties of 2-((R-5-Chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a Novel and Selective α1A-Adrenergic Partial Agonist, in in Vitro and in Vivo Models of Urethral Function
Kelly Conlon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
Michael A. Weber et al.
LANCET (2009)
Chemokine Signaling and the Management of Neuropathic Pain
Fletcher A. White et al.
MOLECULAR INTERVENTIONS (2009)
A novel 1-indanone isolated from Uvaria afzelii roots
T. Okpekon et al.
NATURAL PRODUCT RESEARCH (2009)
Promise of mGluR2/3 activators in psychiatry
P. Jeffrey Conn et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Novel 2-imidazoles as potent, selective and CNS penetrant α1A adrenoceptor partial agonists
Lee R. Roberts et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Potent, selective MCH-1 receptor antagonists
Shawn D. Erickson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Novel 2-imidazoles as potent and selective α1A adrenoceptor partial agonists
Gavin A. Whitlock et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
In vitro and in vivo profiling of fadolmidine, a novel potent α2-adrenoceptor agonist with local mode of action
Jyrki Lehtimaki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
New benzoyl glucosides and cytotoxic pterosin sesquiterpenes from Pteris ensiformis burm.
Yung-Husan Chen et al.
MOLECULES (2008)
Mild, efficient Friedel-Crafts acylations from carboxylic acids using cyanuric chloride and AlCl3
Cyrous O. Kangani et al.
ORGANIC LETTERS (2008)
Prostaglandin F-2 alpha and its receptor as activators of human decidua
Shintaro Makino et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2007)
C-(4,5,6-trimethoxyindan-1-yl)methanamine:: A mescaline analogue designed using a homology model of the 5-HT2A receptor. (vol 49, pg 4270, 2006)
Thomas H. McLean et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance
Katsuya Dezaki et al.
DIABETES (2006)
Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity
Anthony L. Handlon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2
NV Serbina et al.
NATURE IMMUNOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor
C Bonnefous et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response
M Steinhoff et al.
ENDOCRINE REVIEWS (2005)
Protease-activated receptors: Contribution to physiology and disease
VS Ossovskaya et al.
PHYSIOLOGICAL REVIEWS (2004)
Transformation of 1,5-and 1,6-dienes to carbocycles by hydrozirconation and oxidation with cerium(IV) compounds
T Azemi et al.
TETRAHEDRON (2004)
Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for obesity the treatment of obesity
TJ Kowalski et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Upregulation of orphan nuclear receptor Nur77 following PGF2α, Bimatoprost, and Butaprost treatments.: Essential role of a protein kinase C pathway involved in EP2 receptor activated Nur77 gene transcription
YB Liang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Three new resveratrol oligomers from the stem bark of Vatica pauciflora
T Ito et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters
H Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
JM Savola et al.
MOVEMENT DISORDERS (2003)
Indanyl piperazines as melatonergic MT2 selective agents
RJ Mattson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Y Itoh et al.
NATURE (2003)
Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate
MA Asnicar et al.
ENDOCRINOLOGY (2002)
Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists
K Fukatsu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists
O Uchikawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei
AJ Harmar et al.
CELL (2002)
Improvement in the selectivity and metabolic stability of the serotonin 5-HT1A ligand, S 15535:: A series of cis- and trans-2-(arylcycloalkylamine) 1-indanols
JL Peglion et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide
EJ Goetzl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Comparison of α1-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models
ME Brune et al.
JOURNAL OF UROLOGY (2001)
Preclinical evaluation of CHF3381 as a novel antiepileptic agent
G Villetti et al.
NEUROPHARMACOLOGY (2001)
Potential antidepressants displayed combined α2-adrenoceptor antagonist and monoamine uptake inhibitor properties
AA Cordi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
G protein-coupled prostanoid receptors and the kidney
MD Bryer et al.
ANNUAL REVIEW OF PHYSIOLOGY (2001)
CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
BT Fife et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
